Clinical Trial Update: Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of subcutaneous belimumab with intravenous rituximab co-administration in primary Sjögren's syndrome; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Belimumab (belimumab)
• Rituximab (rituximab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-06-09